TrialEuropean journal of cancer (Oxford, England : 1990)2019

Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial.

Michael J Morris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.